CClinicalTrials.gg
CompletedNCT03664726MINDDUpdated Feb 21, 2023Results posted

MINDD 3: Prediabetes and Delay Discounting

An interventional study of Episodic Future Thinking and Episodic Recent Thinking in PreDiabetes, sponsored by Leonard Epstein. Completed at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-21.

Sponsored by Leonard Epstein · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The proposed research will translate research on delay discounting to the prevention of Type 2 diabetes (T2D) in persons with prediabetes. In this study, the investigators will verify target engagement (DD) by examining if EFT improves DD under conditions shown to increase discounting of the future. Prediabetics will be randomized to receive EFT/ERT in a factorial design when experiencing simulated poverty/neutral conditions, respectively. The effects will be measured on DD. The investigators predict that poverty conditions will increase discounting of the future for ERT subjects, but those receiving EFT will show levels of DD similar to levels observed for participants in the wealth condition.

Read the detailed description

The prevention of Type 2 diabetes in an obese person with prediabetes requires developing a healthier lifestyle. The rational approach for someone with prediabetes would be to eat healthier, be more active, lose weight, and manage their comorbidities. However, preliminary research suggests that individuals with Type 2 diabetes discount the future and engage in behaviors that maximize current pleasure and short-term gain; thus, daily choices needed to improve future health are rare in this population. Delay discounting (DD) describes the choice of smaller immediate versus larger delayed rewards. This behavioral process is related to a wide variety of health choices, ranging from preventive health to behavioral and medical regimen adherence, including regimens used for Type 2 diabetes. The investigators believe that DD provides a target for one type of self-regulation that can improve a wide variety of health behaviors and medical adherence.

Research from our laboratories has shown that episodic future thinking (EFT), a form of prospection which reduces the bias towards immediate gratification, activates brain regions involved in planning and prospection such that future rewards have increased value and the extent of delay discounting is reduced. Cueing individuals to think about future events during inter-temporal decision-making reduces the rate of DD, eating in and outside of the laboratory, and smoking behavior. The overarching goal of this research is to use an experimental medicine approach to translate basic research on DD and EFT into clinical interventions to prevent the transition from prediabetes to a diagnosis of Type 2 diabetes.

02

Conditions studied

  • PreDiabetes

Keywords

  • Delay Discounting, Episodic Future Thinking
03

In context

Prediabetic State

999 studies on the registry are indexed under Prediabetic State; 238 are open to participants now.

This study's enrollment of 78 is above the median of 65 across 844 interventional studies indexed under Prediabetic State.

Browse Prediabetic State studies →

Lead sponsor

This is the only study on the registry with Leonard Epstein as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Prediabetes: Participants must have a diagnosis of prediabetes within the last 2 years or meet criteria for prediabetes. The American Diabetes Association guidelines defines prediabetes as Fasting Plasma Glucose (FPG) 100-125 mg/dl, 2h glucose 140-199 mg/dl after Oral Glucose Tolerance Test (OGTT), or hemoglobin A1c (HbA1c) approximately 5.7-6.4%.
  • Comorbidities: Participants must have a history of comorbid diagnosis such as hypertension and/or hyperlipidemia to participate in the behavioral portion of this study. Hypertension is defined as blood pressure greater than 140/90 on two separate occasions at least one week apart, or medical management for hypertension (i.e. medications including Lisinopril and Diovan). Dyslipidemia is defined by LDL greater than 130 mg/dl, or non-fasting non HDL cholesterol ≥160mg/dL or medical management for dyslipidemia (medications including Niacin, Lovastatin).

Exclusion criteria

Exclusion Criteria:

  • Type 2 Diabetes: Individuals will be excluded if they have Type 2 Diabetes.
  • Pregnancy: Women who are pregnant or lactating will be excluded from participation.
  • Conditions that affect adherence: Participants should not have a condition that would limit participation which include medical conditions that would affect individuals' ability to use the computer for prolonged period of time; leave the individual unable to ambulate; or current diagnoses of an eating disorder (anorexia, bulimia,), unmanaged psychiatric disorder (depression, anxiety, attention deficit hyperactivity disorder (ADHD), schizophrenia), or an intellectual impairment that would impact study adherence.
  • Abnormal glucose related to medications: Participants should not be taking medications that would limit participation and cause abnormal glucose levels (e.g. atypical antipsychotic medications or glucocorticoids) including diabetic drugs such as Metformin.
  • Unwilling or unable to eat study food: Participants who are unwilling or not able to eat the study food (a PowerBar) will not be able to take part in this study.

Prior participation in similar studies: Individuals who have recently participated in a laboratory study using similar methods may also be excluded.

  • Do not meet discounting criteria: Individuals who do not meet discounting criteria (e.g. nonsystematic discounting) on a delay discounting task may be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
78 participants (actual)

Study arms

  • Experimental
    Episodic Future Thinking (EFT) & Neutral Narrative

    Participants will complete an episodic thinking task to generate episodic cues where they will list and describe events for different time periods.The episodic component of the thinking task will occur while the participants are asked to describe what they are imagining about each event (e.g., vacations, weddings, parties, and so forth). EFT participants will list positive future events they are looking forward to and list events that could happen at different general future time points (e.g., 1 month, 2-6 months, 7-12 months). Participants will also be asked to think about a neutral narrative that describes a situation in which changes to their income are neutral or minimal

    Behavioral: Episodic Future Thinking · Behavioral: Neutral Narrative

  • Active comparator
    Episodic Recent Thinking (ERT) & Neutral Narrative

    Participants will complete an episodic recent thinking task to generate episodic cues where they will list and describe events for different time periods. The episodic component of the thinking task will occur while the participants are asked to describe what they are imagining about each event. ERT participants will list positive recent events they enjoyed and list events that happened recently (e.g. 1 - 7 days ago). Participants will also be asked to think about a neutral narrative that describes a situation in which changes to their income are neutral or minimal (e.g. department job transfer).

    Behavioral: Episodic Recent Thinking · Behavioral: Neutral Narrative

  • Experimental
    Episodic Future Thinking (EFT) & Scarcity Narrative

    Participants will complete an episodic thinking task to generate episodic cues where they will list and describe events for different time periods.The episodic component of the thinking task will occur while the participants are asked to describe what they are imagining about each event (e.g., vacations, weddings, parties, and so forth). EFT participants will list positive future events they are looking forward to and list events that could happen at different general future time points (e.g., 1 month, 2-6 months, 7-12 months). Participants will also be asked to think about a narrative to induce a scarcity mindset by describing a situation in which changes to their income are negative (e.g. loss of job).

    Behavioral: Episodic Future Thinking · Behavioral: Scarcity Narrative

  • Experimental
    Episodic Recent Thinking (ERT) & Scarcity Narrative

    Participants will complete an episodic recent thinking task to generate episodic cues where they will list and describe events for different time periods. The episodic component of the thinking task will occur while the participants are asked to describe what they are imagining about each event. ERT participants will list positive recent events they enjoyed and list events that happened recently (e.g. 1 - 7 days ago). Participants will also be asked to think about a narrative to induce a scarcity mindset by describing a situation in which changes to their income are negative (e.g. loss of job).

    Behavioral: Episodic Recent Thinking · Behavioral: Scarcity Narrative

Interventions

  • BehavioralEpisodic Future Thinking

    Participants will be instructed to use their episodic future cues as they engage in different decision making tasks.

    Also known as: EFT

  • BehavioralEpisodic Recent Thinking

    Participants will be instructed to use their episodic recent cues as they engage in different decision making tasks.

    Also known as: ERT

  • BehavioralScarcity Narrative

    Participants will read a narrative to induce a scarcity mindset, in which they are asked to imagine a scenario in which they have lost their job and have no current secondary income.

    Also known as: Scarcity

  • BehavioralNeutral Narrative

    Participants will read a narrative in which they are asked to imagine a scenario in which they have been transferred between departmental jobs, with little change in salary/commute.

    Also known as: Neutral

06

What researchers measure

Primary outcomes

  1. Change in Delay Discounting

    Delay Discounting will be measured using monetary Delay Discounting tasks with $100 as the delayed reward. Delay discounting is assessed using Area Under the Curve (AUC), or time\*indifference point/delay. AUC for delay discounting included time (x-axis) and indifference point (y-axis), or the amount of money at which the immediate and delayed options are approximately equal. Indifference points are a percentage of the max amount (range 0 - 100). AUC adds the calculated areas for each timepoint from the previous timepoint. Ordinal AUC was used as the measure. Ordinal AUC normalizes the horizontal axis time points to have equal distances between them. AUC ranges from 0 (most impulsive, did not choose delay) to 100 (least impulsive, always chose delay). This is the difference in delay discounting between session 2 and session 1. Larger numbers indicate a decrease in discounting, or less impulsive, while smaller/negative numbers indicate an increase in discounting, or more impulsive.

    Time frame: Delay Discounting will be measured at baseline (session 1) and after receiving EFT/ERT and Scarcity/Narrative (within about 2 weeks)

  2. Reinforcing Value of Food

    Reinforcing value of food was measured using the relative reinforcing efficacy questionnaire in which participants are asked how many portions of food they would purchase at various prices. Intensity is the number of portions they would purchase and consume when the price is $0.

    Time frame: Session 2

Secondary outcomes

  1. Change in Working Memory Span

    Backwards Corsi is a task that assesses visuo-spatial short term working memory. Participants are asked to watch a series of squares on a computer screen and repeat the sequence backwards. This is done several times and the highest number of correctly remembered locations is the span score, with a possible score of 2 - 9 locations total. Span score represents the number of locations that can be recalled backwards. Larger span scores indicate more locations can be remembered and recalled correctly backwards. This is the difference in score between session 2 and session 1. Larger numbers indicate greater change during the experimental manipulation or better working memory, while smaller or negative numbers indicates lower working memory during the experimental manipulation versus baseline. Numbers close to 0 represent little to no change.

    Time frame: Working Memory will be measured at baseline (session 1) and after receiving EFT/ERT Scarcity/Neutral intervention (up to 2 weeks post-baseline)

07

Results

Posted Aug 4, 2022

Participant flow

Participant flow — Overall Study
MilestoneEpisodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral Narrative
Started21201819
Completed21201819
Not completed0000

Outcome measures

PrimaryChange in Delay Discounting

Delay Discounting will be measured using monetary Delay Discounting tasks with $100 as the delayed reward. Delay discounting is assessed using Area Under the Curve (AUC), or time\*indifference point/delay. AUC for delay discounting included time (x-axis) and indifference point (y-axis), or the amount of money at which the immediate and delayed options are approximately equal. Indifference points are a percentage of the max amount (range 0 - 100). AUC adds the calculated areas for each timepoint from the previous timepoint. Ordinal AUC was used as the measure. Ordinal AUC normalizes the horizontal axis time points to have equal distances between them. AUC ranges from 0 (most impulsive, did not choose delay) to 100 (least impulsive, always chose delay). This is the difference in delay discounting between session 2 and session 1. Larger numbers indicate a decrease in discounting, or less impulsive, while smaller/negative numbers indicate an increase in discounting, or more impulsive.

Time frame:
Delay Discounting will be measured at baseline (session 1) and after receiving EFT/ERT and Scarcity/Narrative (within about 2 weeks)
Reported as:
Mean · time*indifference point/delay
Change in Delay Discounting
time*indifference point/delayEpisodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) and Neutral NarrativeEpisodic Recent Thinking (ERT) and Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral Narrative
Change in Delay Discounting-0.002 ± 0.0320.108 ± 0.032-0.069 ± 0.0340.035 ± 0.033
Statistical analysis
  • Episodic Future Thinking (EFT) & Scarcity Narrative vs Episodic Future Thinking (EFT) and Neutral Narrative vs Episodic Recent Thinking (ERT) and Scarcity Narrative vs Episodic Recent Thinking (ERT) & Neutral Narrative · ANOVA · p = 0.0034 (Comparison of differences by group)
PrimaryReinforcing Value of Food

Reinforcing value of food was measured using the relative reinforcing efficacy questionnaire in which participants are asked how many portions of food they would purchase at various prices. Intensity is the number of portions they would purchase and consume when the price is $0.

Time frame:
Session 2
Reported as:
Mean · number of food portions purchased at $0
Reinforcing Value of Food
number of food portions purchased at $0Episodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral Narrative
Reinforcing Value of Food9.9 ± 2.410.7 ± 2.510.6 ± 2.57.4 ± 2.5
Statistical analysis
  • Episodic Future Thinking (EFT) & Scarcity Narrative vs Episodic Future Thinking (EFT) & Neutral Narrative vs Episodic Recent Thinking (ERT) & Scarcity Narrative vs Episodic Recent Thinking (ERT) & Neutral Narrative · ANOVA · p = 0.76
SecondaryChange in Working Memory Span

Backwards Corsi is a task that assesses visuo-spatial short term working memory. Participants are asked to watch a series of squares on a computer screen and repeat the sequence backwards. This is done several times and the highest number of correctly remembered locations is the span score, with a possible score of 2 - 9 locations total. Span score represents the number of locations that can be recalled backwards. Larger span scores indicate more locations can be remembered and recalled correctly backwards. This is the difference in score between session 2 and session 1. Larger numbers indicate greater change during the experimental manipulation or better working memory, while smaller or negative numbers indicates lower working memory during the experimental manipulation versus baseline. Numbers close to 0 represent little to no change.

Time frame:
Working Memory will be measured at baseline (session 1) and after receiving EFT/ERT Scarcity/Neutral intervention (up to 2 weeks post-baseline)
Reported as:
Mean · number of locations
Change in Working Memory Span
number of locationsEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Neutral NarrativeEpisodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Scarcity Narrative
Change in Working Memory Span0.05 ± 0.480.41 ± 0.510.72 ± 0.490.16 ± 0.48
Statistical analysis
  • Episodic Future Thinking (EFT) & Neutral Narrative vs Episodic Recent Thinking (ERT) & Neutral Narrative vs Episodic Future Thinking (EFT) & Scarcity Narrative vs Episodic Recent Thinking (ERT) & Scarcity Narrative · ANOVA · p = 0.77

Adverse events

Collected over Adverse event data was examined between the initial session and the second session (about 2 weeks).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Episodic Future Thinking (EFT) & Scarcity Narrative0/21 (0%)0/20 (0%)0/21 (0%)
Episodic Future Thinking (EFT) & Neutral Narrative0/20 (0%)0/21 (0%)0/20 (0%)
Episodic Recent Thinking (ERT) & Scarcity Narrative0/18 (0%)0/18 (0%)0/18 (0%)
Episodic Recent Thinking (ERT) & Neutral Narrative0/19 (0%)0/19 (0%)0/19 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Episodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral NarrativeTotal
Mean47.57 ± 12.7250.55 ± 34.4550.61 ± 10.4152.89 ± 11.3850.33 ± 12.51
Sex: Female, Male
Sex: Female, Male(Participants)Episodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral NarrativeTotal
Female1715131661
Male455317
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Episodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral NarrativeTotal
Hispanic or Latino20002
Not Hispanic or Latino1919161973
Unknown or Not Reported01203
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Episodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral NarrativeTotal
American Indian or Alaska Native10102
Asian01001
Native Hawaiian or Other Pacific Islander00000
Black or African American586928
White141181043
More than one race10203
Unknown or Not Reported00101
Region of Enrollment
Region of Enrollment(participants)Episodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral NarrativeTotal
United States2120181978
hbA1c
hbA1c(Participants)Episodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral NarrativeTotal
HbA1c % 5.4-5.6111010940
HbA1c %5.7-6.4101081038
Delay discounting
Delay discounting(time*indifference point/delay)Episodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral NarrativeTotal
$100 Delay Discounting0.54 ± 0.160.49 ± 0.170.52 ± 0.180.51 ± 0.200.51 ± 0.17
$1000 Delay Discounting0.61 ± 0.190.57 ± 0.210.60 ± 0.230.59 ± 0.200.59 ± 0.21
Site Enrollment
Site Enrollment(Participants)Episodic Future Thinking (EFT) & Scarcity NarrativeEpisodic Future Thinking (EFT) & Neutral NarrativeEpisodic Recent Thinking (ERT) & Scarcity NarrativeEpisodic Recent Thinking (ERT) & Neutral NarrativeTotal
University at Buffalo1213111147
Virginia Tech Carilon977831

1 further baseline measures are reported on the registry.

08

Study locations

2 sites
  • University at Buffalo, Department of Pediatrics, Division of Behavioral Medicine
    Buffalo, New York 14214, United States
  • Fralin Biomedical Research Institute, Virginia Tech Carilion
    Roanoke, Virginia 24016, United States
09

References and documents

Publications

  • Stein JS, Craft WH, Paluch RA, Gatchalian KM, Greenawald MH, Quattrin T, Mastrandrea LD, Epstein LH, Bickel WK. Bleak present, bright future: II. Combined effects of episodic future thinking and scarcity on delay discounting in adults at risk for type 2 diabetes. J Behav Med. 2021 Apr;44(2):222-230. doi: 10.1007/s10865-020-00178-7. Epub 2020 Sep 28. PubMed 32989616 ↗
  • Bickel WK, Stein JS, Paluch RA, Mellis AM, Athamneh LN, Quattrin T, Greenawald MH, Bree KA, Gatchalian KM, Mastrandrea LD, Epstein LH. Does Episodic Future Thinking Repair Immediacy Bias at Home and in the Laboratory in Patients With Prediabetes? Psychosom Med. 2020 Sep;82(7):699-707. doi: 10.1097/PSY.0000000000000841. PubMed 32868537 ↗

Study documents

  • Protocol and statistical analysis plan · Jul 20, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided — It is not yet known if there will be a plan to make IPD available

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03664726
Lead sponsor
Leonard Epstein
Collaborators
Virginia Polytechnic Institute and State University
Responsible party
Leonard Epstein (Principal Investigator, State University of New York at Buffalo) — Sponsor-investigator
First posted
Sep 10, 2018
Start date
Feb 12, 2018
Primary completion
Jun 30, 2018
Completion
Jun 30, 2018
Results posted
Aug 4, 2022
Last update
Feb 21, 2023

Study contacts

Leonard H Epstein
principal investigator · SUNY University at Buffalo
Warren K Bickel
principal investigator · Virginia Polytechnic Institute and State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion